Return to NG131 Overview

Prostate cancer: diagnosis and management [NG131]

Measuring the use of this guidance

Recommendation: 1.1.2

Offer people with prostate cancer information tailored to their own needs. This information should be given by a healthcare professional (for example, a consultant or specialist nurse) and may be supported by written and visual media. [2008]

What was measured: Proportion of prostate cancer patients who reported that, when they were told they had cancer, they were given written information about the type of cancer they had and it was easy to understand.
Data collection end: June 2018
81.6%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.


Recommendation: 1.1.3

Offer people with prostate cancer advice on how to get information and support from websites, local and national cancer information services, and from cancer support groups. [2008]

What was measured: Proportion of prostate cancer patients who reported that hospital staff gave them information about support or self-help groups for people with cancer.
Data collection end: June 2018
89%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.


Recommendation: 1.1.5

Find out the extent to which the person wishes to be involved in their decision making, and ensure that they have sufficient information to do so. [2008]

What was measured: Proportion of prostate cancer patients who said that they were definitely involved as much as they wanted to be in decisions about their care and treatment.
Data collection end: June 2018
80.9%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.


Recommendation: 1.1.10

Tell people with prostate cancer: • about treatment options and their risks and benefits in an objective, unbiased manner and • that there is limited evidence for some treatment options. [2014]

What was measured: Proportion of prostate cancer patients who reported that, before their cancer treatment started, their treatment options were explained to them.
Data collection end: June 2018
81.6%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.


Recommendation: 1.1.12

Tell people with prostate cancer and their partners or carers about the effects of prostate cancer and the treatment options on their: • sexual function • physical appearance • continence • other aspects of masculinity. Support people and their partners or carers in making treatment decisions, taking into account the effects on quality of life as well as survival. [2008]

What was measured: Proportion of prostate cancer patients who reported that the possible side effects of treatment(s) were explained to them in a way they could understand.
Data collection end: June 2018
72.2%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.

What was measured: Proportion of prostate cancer patients who said that hospital staff discussed with them or gave them information about the impact cancer could have on their day to day activities.
Data collection end: June 2018
85.5%
Area covered: England
Source: Quality Health. National Cancer Patient Experience Survey.



 Return to NG131 Overview